“Good Morning America” anchor Whit Johnson revealed that his 23andMe test was a “missing link” that led to a “bombshell” discovery for his family after the company filed for bankruptcy — sparking ...

Genetics testing company 23andMe on Monday announced a deal to be acquired by biotechnology company Regeneron. The $256 million sale is subject to court oversight, and still needs approval. The sale ...

In response, Vermont lawmakers are considering a consumer protection bill that would regulate how genetic testing companies collect, use and share Vermonters’ data. An amended version of the bill was ...

At SXSW in Austin this weekend, consumer genomics company 23andMe unveiled its latest test, a predisposition report on Type 2 diabetes. The test, which has not undergone FDA clearance and does not ...

Some claimants may receive thousands of dollars.

Genetic testing firm 23andMe is set to be acquired by drug company Regeneron Pharmaceuticals following its bankruptcy in March, the companies announced on Monday, May 19. Regeneron purchased the ...

The FDA authorized 23andMe to market its pharmacogenetic report Oct. 31, marking the agency’s first time greenlighting a direct-to-consumer DNA test for this purpose. Pharmacogenetics is an area of ...

Florida Attorney General James Uthmeier issued a consumer alert after 23andMe filed for bankruptcy on March 23, 2025. He ...

American biotechnology company 23andMe filed for Chapter 11 bankruptcy this month, after several quarters of falling revenue. The filing has put the data of millions of users’ data up for grabs, as ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million people, to the drug developer Regeneron Pharmaceuticals for $256 million. The ...